Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown

Anandamide (AEA) and 2-arachidonyl glycerol (2-AG), endogenous ligands for the CB1 and CB2 cannabinoid receptors, are referred to as endocannabinoids because they mimic the actions of delta 9-tetrahydrocannabinol (Δ 9-THC), a plant-derived cannabinoid. The processes by which AEA and 2-AG are biosynt...

Full description

Saved in:
Bibliographic Details
Published in:Neuropharmacology Vol. 55; no. 7; pp. 1095 - 1104
Main Authors: Placzek, Ekaterina A., Okamoto, Yasuo, Ueda, Natsuo, Barker, Eric L.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-12-2008
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anandamide (AEA) and 2-arachidonyl glycerol (2-AG), endogenous ligands for the CB1 and CB2 cannabinoid receptors, are referred to as endocannabinoids because they mimic the actions of delta 9-tetrahydrocannabinol (Δ 9-THC), a plant-derived cannabinoid. The processes by which AEA and 2-AG are biosynthesized, released, taken up by cells and hydrolyzed have been of much interest as potential therapeutic targets. In this review we will discuss the progress that has been made to characterize the primary pathways for AEA and 2-AG formation and breakdown as well as the role that specialized membrane microdomains known as lipid rafts play in these processes. Furthermore we will review the recent advances made to track and detect AEA in biological matrices.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Feature-3
ObjectType-Review-1
ISSN:0028-3908
1873-7064
DOI:10.1016/j.neuropharm.2008.07.047